Molecular diagnostics and therapeutics for ectopic pregnancy

ACOG Practice Bulletin No. 94: Medical Management of Ectopic Pregnancy

(2017)   OBSTETRICS AND GYNECOLOGY

Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series

(2014) A.W. Horne et al.   HUMAN REPRODUCTION

Maternal Serum Disintegrin and Metalloprotease Protein-12 in Early Pregnancy as a Potential Marker of Adverse Pregnancy Outcomes

(2014) Jiexia Yang et al.   PLoS One

Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases

(2013) Zhen Zhao et al.   CLINICAL BIOCHEMISTRY

Single point biochemical measurement algorithm for early diagnosis of ectopic pregnancy

(2013) Stephen A. Butler et al.   CLINICAL BIOCHEMISTRY

Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies

(2013) S Jang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Targeted Nanoparticle Delivery of Doxorubicin Into Placental Tissues to Treat Ectopic Pregnancies

(2013) Tu'uhevaha J. Kaitu'u-Lino et al.   ENDOCRINOLOGY

Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodies

(2013) Caroline Robert et al.   EUROPEAN JOURNAL OF CANCER

Combination Gefitinib and Methotrexate Compared With Methotrexate Alone to Treat Ectopic Pregnancy

(2013) Monika M. Skubisz et al.   OBSTETRICS AND GYNECOLOGY

Effects of Gefitinib, an Epidermal Growth Factor Receptor Inhibitor, on Human Placental Cell Growth

(2013) Ulrika W. Nilsson et al.   OBSTETRICS AND GYNECOLOGY

The role of leukemia inhibitory factor in tubal ectopic pregnancy

(2013) T. Krishnan et al.   PLACENTA

Shotgun Proteomics Identifies Serum Fibronectin as a Candidate Diagnostic Biomarker for Inclusion in Future Multiplex Tests for Ectopic Pregnancy

(2013) Jeremy K. Brown et al.   PLoS One

Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol

(2013) Andrew W Horne et al.   BMJ Open

Serum activin A does not predict ectopic pregnancy as a single measurement test, alone or as part of a multi-marker panel including progesterone and hCG

(2012) Joshua Warrick et al.   CLINICA CHIMICA ACTA

Possible Role of Adrenomedullin In the Pathogenesis of Tubal Ectopic Pregnancy

(2012) S. B. Liao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evaluation of ADAM-12 as a Diagnostic Biomarker of Ectopic Pregnancy in Women with a Pregnancy of Unknown Location

(2012) Andrew W. Horne et al.   PLoS One

The financial costs to patients of diagnosing and excluding ectopic pregnancy

(2012) Holger W Unger et al.   JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE

Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies

(2012) J. Verhaegen et al.   BMJ-British Medical Journal

Molecular diagnosis of ectopic pregnancy

(2011) Kurt Barnhart et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy

(2011) Mary E. Rausch et al.   FERTILITY AND STERILITY

The use of novel biochemical markers in predicting spontaneously resolving 'pregnancies of unknown location'

(2011) M. Chetty et al.   HUMAN REPRODUCTION

Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) and Serum Placental Growth Factor (PlGF) as Biomarkers for Ectopic Pregnancy and Missed Abortion

(2011) Alexandros Daponte et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Diagnosis and management of ectopic pregnancy

(2011) V. N. Sivalingam et al.   JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE

The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy

(2010) Andrew W Horne et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome

(2010) Kurt Barnhart et al.   FERTILITY AND STERILITY

Placental Growth Factor: A Promising Diagnostic Biomarker for Tubal Ectopic Pregnancy

(2010) Andrew W. Horne et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Systematic Discovery of Ectopic Pregnancy Serum Biomarkers Using 3-D Protein Profiling Coupled with Label-free Quantitation

(2010) Lynn A. Beer et al.   JOURNAL OF PROTEOME RESEARCH

Inhibin A: marker for diagnosis of ectopic and early abnormal pregnancies

(2010) Shimon Segal et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Economic evaluation of diagnosing and excluding ectopic pregnancy

(2009) C.J. Wedderburn et al.   HUMAN REPRODUCTION

The use of serum inhibin A and activin A levels in predicting the outcome of 'pregnancies of unknown location'

(2009) E. Kirk et al.   HUMAN REPRODUCTION

Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases

(2008) H. L. LaMarca et al.   HUMAN REPRODUCTION

Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis

(2008) F. Mol et al.   HUMAN REPRODUCTION UPDATE

Endometrial Inhibin/Activin β-B Subunit Expression Is Related to Decidualization and Is Reduced in Tubal Ectopic Pregnancy

(2008) A. W. Horne et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparison of MB Fraction of Creatine Kinase Mass and Troponin I Serum Levels With Necropsy Findings in Acute Myocardial Infarction

(2007) Thiago Nogueira Costa et al.   AMERICAN JOURNAL OF CARDIOLOGY